High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

BACKGROUND: High-flow nasal cannula (HFNC) can improve ventilatory function in patients with acute COPD exacerbation. However, its effect on clinical outcomes remains uncertain. METHODS: This randomized controlled trial was conducted from July 2017 to December 2020 in 16 tertiary hospitals in China....

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jingen, Gu, Sichao, Lei, Wei, Zhang, Jihua, Wei, Hui, Liu, Chao, Zhang, Han, Lu, Rongli, Zhang, Liqiong, Jiang, Mingyan, Hu, Chao, Cheng, Zhenshun, Wei, Chaojie, Chen, Yusheng, Lu, Fengfeng, Chen, Min, Bi, Hong, Liu, Hui, Yan, Cunzi, Teng, Hong, Yang, Yang, Liang, Chen, Ge, Yanlei, Hou, Pengguo, Liu, Jialin, Gao, Weiwei, Zhang, Yi, Feng, Yingying, Tao, Cheng, Huang, Xu, Pan, Pinhua, Luo, Hong, Yun, Chunmei, Zhan, Qingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013098/
https://www.ncbi.nlm.nih.gov/pubmed/35428349
http://dx.doi.org/10.1186/s13054-022-03973-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013098/
https://www.ncbi.nlm.nih.gov/pubmed/35428349
http://dx.doi.org/10.1186/s13054-022-03973-7

Ejemplares similares